Recombinate Health Co-Invest I, LLC has successfully filed a new offering under Rule 506(b) of the Securities Act, raising a total of $2.91 million. This offering is significant as it reflects the growing activity in private equity fundraising, a sector that continues to attract investor interest.

Recombinate Health Co-Invest I, LLC is a limited liability company incorporated in Delaware. The company is based in San Francisco, California, with its business address listed as 15 Onondaga Ave., #12355, San Francisco, CA 94112. The firm focuses on pooled investment funds, specifically private equity funds, and has no publicly traded stock or exchange listings.

The recent SEC filing, dated November 4, 2026, indicates that the company has completed its offering with a total amount sold of $2.91 million. The filing notes that the offering was made under the exemptions provided by items 06b, 3C, and 3C.1 of the Securities Act. It also states that the offering has attracted 26 investors, all of whom are accredited.

"The total offering amount is $2,910,000, with the total amount sold also being $2,910,000," the filing states.

This successful fundraising effort may impact various stakeholders, including the company’s management team, which consists of Matthew Scott Hollingsworth and Matthew Survis, both identified as managing partners. Their roles as executive officers and promoters suggest they are actively involved in the strategic direction and operational management of the firm.

As for what’s next, the filing does not specify any upcoming actions or future plans following this offering. Investors and interested parties will need to wait for further updates from Recombinate Health Co-Invest I, LLC.